Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol - The PIPAC-OPC2 Trial

NCT03287375 is registered in ClinicalTrials.gov with Michael Bau Mortensen as lead sponsor.

NCT NCT03287375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03287375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol - The PIPAC-OPC2 Trial
Lead sponsor
Michael Bau Mortensen
Phase
Phase 2
Overall status
Completed
Start date
December 1, 2016
Completion date
October 1, 2022
Enrollment
143 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapeutic toxicity, chemotherapy effect, histologic progression, peritoneal metastases, peritoneal neoplasms, peritoneum; carcinomatosis, quality of life